MedTrace Logo

Efficacy of Mifepristone - Prostaglandin Analogue Combination in Medical Termination of Pregnancy Beyond 7 Weeks of Amenorrhea

NCT02614781 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 892

Last updated 2016-07-11

No results posted yet for this study

Summary

This study is a non-interventional prospective, multicenter, longitudinal study conducted in France, among a representative sample of public and/or private birth control centers.

The aim of the study is to assess, in real-life settings, the success rate of the protocol Mifegyne / prostaglandin analogue in patients asking for medical abortion either prior or beyond 7 weeks of amenorrhea.

Conditions

  • Medical Termination of Pregnancy

Sponsors & Collaborators

  • Nordic Pharma SAS

    lead INDUSTRY

Principal Investigators

  • Hélène HERMAN-DEMARS, MD · NORDIC PHARMA

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02614781 on ClinicalTrials.gov